News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Takeda Cambridge in Second Deal to Expand Use of Dimerix Bioscience’s GPCR-HIT Platform


4/13/2011 10:30:59 AM

PERTH, Australia--(BUSINESS WIRE)--Dimerix Bioscience Pty Ltd today announced that it has entered into a second research program with Takeda Cambridge Limited, a UK based subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company. This new program is in addition to the continuing research program announced on 15 April 2010.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES